- American City Business Journals•2 days ago
Stereotaxis Inc. has secured $24 million in equity financing and is retiring $13 million in debt. The St. Louis-based maker of medical devices for treating cardiac arrhythmias announced Tuesday that it will receive a $24 million upfront investment upon the issuance of preferred stock with a conversion price of 65 cents, a 10 percent premium to the stock’s closing price Monday. Stereotaxis could receive up to an additional $25.8 million in the future upon the exercise of warrants.
- GlobeNewswire•2 days ago
-$24 Million Equity Investment-- Recruitment of Highly Experienced Board Members-- Retirement of Debt at Significant Discount-. LOUIS, Sept. 27, 2016-- Stereotaxis, Inc., a global leader in innovative ...
- Capital Cube•17 days ago
Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Stereotaxis, Inc. Here are 5 ETF’s with the largest exposure to STXS-US. Comparing the performance and risk of Stereotaxis, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
Stereotaxis Inc. (STXS)
NasdaqCM - NasdaqCM Delayed Price. Currency in USD
|Day's Range||0.74 - 0.81|
|52wk Range||0.54 - 1.95|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-2.31|
|Avg Vol (3m)||100,935|
|Dividend & Yield||N/A (N/A)|